Researchers find two understudied 'forever chemicals' raise liver cancer risk - Medical Xpress
Researchers find two understudied 'forever chemicals' raise liver cancer risk Medical Xpress
Researchers find two understudied 'forever chemicals' raise liver cancer risk Medical Xpress
Rethinking HCC Surveillance and Treatment Amid a Shifting Risk Landscape CancerNetwork
Lee Joo Ahn: The Actor Who Donated His Liver to Save His Mother From Liver Cancer Oncodaily
Two Lesser-Known Forever Chemicals Tied to Up to 2.5 Times the Odds of Liver Cancer in USC Study Medical Daily
Intratumoral treatments transform liver cancer care Mayo Clinic
Philadelphia Marathon runners turn personal battles with cancer into a mission for a cure FOX 29 Philadelphia
A 3-Year-Old's Cancer Disappeared After Doctors Reprogrammed His Own Immune Cells ScienceAlert
GLP-1 Receptor Agonists in MASH (Fatty Liver Disease): Emerging Therapeutic Potential News-Medical
Electrical Biosensors for Liver Cancer Liquid Biopsy Face Translation Hurdles Bioengineer.org
How a Patient with Liver Cancer Found Lifesaving Options UC San Diego Health
Review Reveals Real-World Results of New, Incisionless Liver Cancer Treatment UVA Health
Predictive biomarker for liver cancer associated with survival outcomes, effectiveness of systemic therapy Medical Xpress
Liver Cancer Progression Slowed by Adding Immunotherapy to TACE Memorial Sloan Kettering Cancer Center
Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women’s health initiative randomized trials Nature
MRI-based approach could provide a new way to detect and monitor fatty liver disease News-Medical
Review Maps Cell Specific Ferroptosis and Immune Mechanisms in Liver Cancer Bioengineer.org
Artificial Intelligence Shows Diagnostic Promise in Liver Cancer but Lacks Outcome Evidence Bioengineer.org
Aspirin Modulates ZNF24 Protein to Suppress Immune Evasion in Liver Cancer Bioengineer.org
Lactate Promotes Faithful Mitosis in Liver Cancer Cells via Protein Lactylation Bioengineer.org
Narrow Margins Match Wide Resection in Liver Cancer After Conversion Therapy Bioengineer.org
Social Support Strongly Influences Advance Care Planning in Advanced Liver Cancer Bioengineer.org
RNA Surveillance Factor SMG7 Drives Liver Tumor Growth Under Metabolic Stress Bioengineer.org
Mamba-Based CT Model Predicts Early Pancreatic Cancer Liver Metastasis and Therapy Benefit Bioengineer.org
Liver cancer survivor thankful for immunotherapy clinical trial UT MD Anderson
Our Lady of Lourdes brings non-invasive liver cancer treatment to Acadiana KATC
Pathological Response Predicts Lower Recurrence in Liver Cancer Perioperative Immunotherapy Bioengineer.org
Lafayette patients gain incision-free liver tumor treatment option The Daily Advertiser | Lafayette, Louisiana
Missouri hospital treats liver cancer with bubbles, sound waves that ‘liquefy’ tumors American Hospital Association
Act of kindness at Utah Build-A-Bear sparks holiday fundraiser for families affected by cancer KSL
Y90-radioembolization radiation therapy for liver cancer patients UT MD Anderson
A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments The Rockefeller University
Case Study Reports Delayed Autoimmune Myasthenia Gravis Following Rare Liver Tumor Resection Bioengineer.org
Global Study Links Country Income Levels to Disparities in Gastrointestinal Cancers Bioengineer.org
One in three Britons has fatty liver disease – here’s how to keep yours healthy The Telegraph
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients Rutgers University
Drug lifts barrier for immunotherapy to fight rare liver cancer Cornell Chronicle
Cancer and HIV/AIDS in Ghana: What the Government Must Devote to Its Citizens Modern Ghana
Hepatitis C and liver cancer: What to know UT MD Anderson
MASLD and MASH: Fatty Liver Disease and Cancer Risk American Cancer Society
Five Things You May Not Know About Liver Cancer—from Managing Risks to Treating Disease NYU Langone Health